RIPK1 and neoplasm: Furthermore, M2‐type cells polarized to immunosuppression were shown to have elevated expression of RIPK1 in a PDA model, which can restart adaptive immune responses and inhibit tumour development by inducing immune reprogramming of immunosuppressed M2‐type cells using gsk547, an inhibitor of stat1.146